VVOS - Vivos Therapeutics GAAP EPS of -$0.18 misses by $0.04 revenue of $3.4M misses by $0.72M
2023-08-16 16:34:05 ET
More on Vivos Therapeutics
- Vivos Therapeutics, Inc. ( VVOS ) Q1 2023 Earnings Call Transcript
- Vivos stock surges ~30% on acquiring dental product rights from Advanced Facialdontics
- Vivos Therapeutics shares slide premarket on pricing $8M private placement at $1.20/unit
- Vivos spikes 41% on FDA clearance for sleep disorder therapy
- Vivos Therapeutics again delays Q2 2022 results
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
- Earnings data for Vivos Therapeutics
For further details see:
Vivos Therapeutics GAAP EPS of -$0.18 misses by $0.04, revenue of $3.4M misses by $0.72M